|
Volumn 324, Issue 8400, 1984, Pages 427-431
|
ANTI-B1 MONOCLONAL ANTIBODY AND COMPLEMENT TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RELAPSED B-CELL NON-HODGKIN'S LYMPHOMA
a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CHLORAMBUCIL;
COMPLEMENT;
COMPLEMENT COMPONENT B1;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PREDNISOLONE;
PROCARBAZINE;
UNCLASSIFIED DRUG;
VINBLASTINE;
VINCRISTINE;
ARTICLE;
BLOOD AND HEMOPOIETIC SYSTEM;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CLINICAL ARTICLE;
DRUG THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPHATIC SYSTEM;
NONHODGKIN LYMPHOMA;
THERAPY;
ADULT;
ANTIBODIES, MONOCLONAL;
B-LYMPHOCYTES;
BONE MARROW TRANSPLANTATION;
COMBINED MODALITY THERAPY;
COMPLEMENT SYSTEM PROTEINS;
FEMALE;
HUMANS;
LYMPHOMA;
MALE;
MIDDLE AGED;
RECURRENCE;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 0021182740
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(84)92907-6 Document Type: Article |
Times cited : (107)
|
References (33)
|